RECRUITING

Smoking Cessation CM for Veterans With or at Risk for Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Tobacco use among US Veterans poses significant health problems and challenges to their overall well-being. The aim of this project is to evaluate the effectiveness of a program called Contingency Management (CM) in helping Veterans quit smoking during lung cancer screening or cancer care at VA clinics. CM is a behavioral treatment that uses rewards to encourage smoking cessation when verified through biological testing. In the first year, the researchers will develop a mobile CM protocol based on feedback from Veterans and healthcare staff through focus groups. In the second year, they will conduct a pilot study to test the feasibility of the mobile CM program along with counseling and medication for 20 Veterans over a five-week period. The success of the pilot study will determine whether to proceed with a larger randomized controlled trial (RCT) in years three to six, comparing the efficacy of mobile CM with standard treatment. The project will take place at SFVA.

Official Title

Contingency Management for Veteran Smokers With or at Risk for Cancer

Quick Facts

Study Start:2024-10-01
Study Completion:2030-03-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06432985

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Human Subjects Involvement and Characteristics: This Proof of Concept and Clinical Trial has three stages. The Proof-of-Concept Phase (Years 1-2) includes a Focus Group phase (Year 1) in which the investigators will recruit both Veterans and non-Veterans (VA clinical staff); and a Pilot Study (Year 2) in which the investigators will recruit Veterans in LCS or cancer treatment at San Francisco VA Healthcare System (SFVAHCS). If the Pilot Study is successful, the investigators will recruit Veterans in LCS or cancer treatment for the RCT (Years 3-6).
  2. * Focus Groups: For Focus Groups (Year 1), the investigators will recruit both Veterans and VA clinical staff at SFVAHCS.
  3. * Age 18 years or older
  4. * Veteran eligible for VA healthcare
  5. * English-speaking
  6. * Received SFVAHCS cancer monitoring or treatment or LCS within the past 24 months
  7. * Active cigarette smoking within the past 24 months
  8. * Have access to Wi-Fi and a device that supports audio and video communication
  9. * Current member of clinical staff at the SFVAHCS
  10. * Have participated in the care of at least 5 VA cancer or LCS patients in the past 6 months
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Ellen Herbst, MD
CONTACT
(415) 221-4810
Ellen.Herbst@va.gov
Madeline Martinez Rivas, PhD
CONTACT
(415) 221-4810
madeline.martinezrivas@va.gov

Principal Investigator

Ellen Herbst, MD
PRINCIPAL_INVESTIGATOR
San Francisco VA Medical Center, San Francisco, CA

Study Locations (Sites)

San Francisco VA Medical Center, San Francisco, CA
San Francisco, California, 94121-1563
United States

Collaborators and Investigators

Sponsor: VA Office of Research and Development

  • Ellen Herbst, MD, PRINCIPAL_INVESTIGATOR, San Francisco VA Medical Center, San Francisco, CA

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-01
Study Completion Date2030-03-30

Study Record Updates

Study Start Date2024-10-01
Study Completion Date2030-03-30

Terms related to this study

Keywords Provided by Researchers

  • Tobacco
  • Contingency Management
  • Lung Cancer

Additional Relevant MeSH Terms

  • Tobacco Use Disorder
  • Substance Use Disorder